• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响糖尿病性黄斑水肿患者玻璃体内注射贝伐单抗和曲安奈德治疗的因素

Factors Influencing Intravitreal Bevacizumab and Triamcinolone Treatment in Patients with Diabetic Macular Edema.

作者信息

Kim Tai K, Shin Hye Y, Kim Su Y, Lee Young C, Lee Mee Y

机构信息

Department of Ophthalmology and Visual Science, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu-si, Gyeonggi-do - Korea.

出版信息

Eur J Ophthalmol. 2017 Nov 8;27(6):746-750. doi: 10.5301/ejo.5000974.

DOI:10.5301/ejo.5000974
PMID:28430331
Abstract

PURPOSE

To evaluate factors associated with response to intravitreal bevacizumab (IVB) and intravitreal triamcinolone acetonide (IVTA) in diabetic macular edema (DME).

METHODS

Ninety-one eyes of 88 patients diagnosed with DME were enrolled in this retrospective chart review. Group 1 included eyes that showed good response to IVB. Group 2 included eyes that did not respond to IVB but responded to IVTA. Group 3 included eyes that responded to neither. Clinical factors, HbA1c, and optical coherence tomography (OCT) findings including patterns of macular edema were compared among the 3 groups.

RESULTS

A total of 44, 27, and 20 eyes were included in groups 1, 2, and 3, respectively. HbA1c was higher in group 3 than in the other groups. Proportion of full (combination of all patterns) type edema was higher in group 3 than in the other 2 groups. In group 1, the proportion of sponge-like diffuse retinal thickening type was higher and cystoid macular edema type was lower than in the other groups.

CONCLUSIONS

The degree of diabetic control and morphologic subtypes with OCT should be considered to better predict the prognosis after treatment in DME.

摘要

目的

评估糖尿病性黄斑水肿(DME)患者玻璃体内注射贝伐单抗(IVB)和玻璃体内注射曲安奈德(IVTA)治疗反应的相关因素。

方法

本回顾性病历研究纳入了88例诊断为DME患者的91只眼。第1组包括对IVB治疗反应良好的眼。第2组包括对IVB无反应但对IVTA有反应的眼。第3组包括对两者均无反应的眼。比较3组之间的临床因素、糖化血红蛋白(HbA1c)以及光学相干断层扫描(OCT)结果,包括黄斑水肿的类型。

结果

第1组、第2组和第3组分别纳入了44只、27只和20只眼。第3组的HbA1c高于其他组。第3组完全(所有类型组合)型水肿的比例高于其他2组。在第1组中,海绵状弥漫性视网膜增厚型的比例高于其他组,而黄斑囊样水肿型的比例低于其他组。

结论

应考虑糖尿病的控制程度以及OCT形态学亚型,以更好地预测DME治疗后的预后。

相似文献

1
Factors Influencing Intravitreal Bevacizumab and Triamcinolone Treatment in Patients with Diabetic Macular Edema.影响糖尿病性黄斑水肿患者玻璃体内注射贝伐单抗和曲安奈德治疗的因素
Eur J Ophthalmol. 2017 Nov 8;27(6):746-750. doi: 10.5301/ejo.5000974.
2
Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema.玻璃体内注射曲安奈德与玻璃体内注射贝伐单抗作为治疗临床上显著黄斑水肿的一线治疗方法的比较。
Retina. 2015 Feb;35(2):272-9. doi: 10.1097/IAE.0000000000000300.
3
Efficacy of intravitreal anti-vascular endothelial growth factor or steroid injection in diabetic macular edema according to fluid turbidity in optical coherence tomography.根据光学相干断层扫描中的液体混浊情况,玻璃体内注射抗血管内皮生长因子或类固醇治疗糖尿病性黄斑水肿的疗效
Korean J Ophthalmol. 2014 Aug;28(4):298-305. doi: 10.3341/kjo.2014.28.4.298. Epub 2014 Jul 22.
4
The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy.玻璃体内注射贝伐单抗和曲安奈德治疗放射性视网膜病变所致黄斑囊样水肿的疗效差异
Semin Ophthalmol. 2015 Jul;30(4):276-80. doi: 10.3109/08820538.2013.847110. Epub 2013 Nov 19.
5
Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.玻璃体内曲安奈德与玻璃体内联合贝伐单抗和地塞米松治疗弥漫性糖尿病黄斑水肿。
Clin Exp Ophthalmol. 2011 Sep-Oct;39(7):673-81. doi: 10.1111/j.1442-9071.2011.02504.x. Epub 2011 Mar 24.
6
Effect of intravitreal triamcinolone acetonide or bevacizumab on choroidal thickness in eyes with diabetic macular edema.玻璃体内曲安奈德或贝伐单抗对糖尿病性黄斑水肿眼脉络膜厚度的影响。
Invest Ophthalmol Vis Sci. 2014 Jun 6;55(6):3979-85. doi: 10.1167/iovs.14-14188.
7
Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema.玻璃体内注射贝伐单抗与贝伐单抗-曲安奈德联合治疗对比黄斑激光光凝治疗糖尿病性黄斑水肿
Eur J Ophthalmol. 2008 Nov-Dec;18(6):941-8. doi: 10.1177/112067210801800614.
8
Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.前瞻性研究曲安奈德与贝伐单抗治疗视网膜中央静脉阻塞继发黄斑水肿。
Retina. 2011 May;31(5):838-45. doi: 10.1097/IAE.0b013e3181f4420d.
9
Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.玻璃体内注射贝伐单抗单独或联合曲安奈德与黄斑光凝治疗糖尿病性黄斑水肿的随机试验
Ophthalmology. 2009 Jun;116(6):1142-50. doi: 10.1016/j.ophtha.2009.01.011. Epub 2009 Apr 19.
10
Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.玻璃体内注射贝伐单抗与曲安奈德治疗持续性弥漫性糖尿病性黄斑水肿的对比治疗评估
Am J Ophthalmol. 2008 May;145(5):854-61. doi: 10.1016/j.ajo.2007.12.031. Epub 2008 Mar 6.

引用本文的文献

1
Suprachoroidal injection of triamcinolone acetonide plus intravitreal bevacizumab in diabetic macular edema: a randomized pilot trial.曲安奈德玻璃体内注射联合玻璃体内贝伐单抗治疗糖尿病性黄斑水肿的随机前瞻性研究
BMC Ophthalmol. 2023 Jan 27;23(1):40. doi: 10.1186/s12886-023-02790-y.
2
Real-World Evidence in the Management of Diabetic Macular Edema with Intravitreal Anti-VEGFs in Asia: A Systematic Literature Review.亚洲玻璃体腔内注射抗血管内皮生长因子治疗糖尿病性黄斑水肿的真实世界证据:一项系统文献综述
Clin Ophthalmol. 2022 Oct 19;16:3503-3526. doi: 10.2147/OPTH.S378392. eCollection 2022.
3
Outcome of intravitreal Avastin® injections in patients with macular oedema in Uganda: a cohort study.
乌干达患者黄斑水肿眼内注射 Avastin® 的疗效:一项队列研究。
Eye (Lond). 2022 May;36(Suppl 1):45-50. doi: 10.1038/s41433-022-02006-5.
4
Factors Affecting a Short-Term Response to Anti-VEGF Therapy in Diabetic Macular Edema.影响糖尿病性黄斑水肿抗VEGF治疗短期反应的因素
Life (Basel). 2021 Jan 25;11(2):83. doi: 10.3390/life11020083.
5
Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography.炎症在光学相干断层扫描对糖尿病性黄斑水肿分类中的作用。
J Diabetes Res. 2019 Dec 20;2019:8164250. doi: 10.1155/2019/8164250. eCollection 2019.
6
Usefulness of Liquid Biopsy Biomarkers from Aqueous Humor in Predicting Anti-VEGF Response in Diabetic Macular Edema: Results of a Pilot Study.房水液体活检生物标志物在预测糖尿病性黄斑水肿抗VEGF治疗反应中的应用价值:一项初步研究结果
J Clin Med. 2019 Nov 2;8(11):1841. doi: 10.3390/jcm8111841.
7
Factors influencing clinical outcomes in patients with diabetic macular edema treated with intravitreal ranibizumab: comparison between responder and non-responder cases.影响玻璃体内注射 ranibizumab 治疗糖尿病性黄斑水肿患者临床结局的因素:应答者与无应答者病例比较。
Sci Rep. 2019 Jul 29;9(1):10952. doi: 10.1038/s41598-019-47241-1.
8
Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.玻璃体内注射地塞米松植入剂Ozurdex®用于初治及难治性不同亚型糖尿病性黄斑水肿患者。
BMC Ophthalmol. 2019 Jan 11;19(1):15. doi: 10.1186/s12886-018-1022-9.